key: cord-0947408-nri2j1k0 authors: Albano, Domenico; Camoni, Luca; Rinaldi, Roberto; Bertagna, Francesco; Giubbini, Raffaele title: (18)F-FDG PET/CT Metabolic Behavior of COVID-19 Pneumonia: A Series of 4 Patients With RT-PCR Confirmation date: 2020-06-08 journal: Clin Nucl Med DOI: 10.1097/rlu.0000000000003150 sha: 01aa031369bae811f1f413f05ff59bf53687d5d6 doc_id: 947408 cord_uid: nri2j1k0 Between March 26 and April 6, among 80 patients who underwent (18)F-FDG PET/CT in our department (Brescia, Italy), 4 showed the presence of an interstitial pneumonia suspected for COVID-19 with reverse transcriptase polymerase chain reaction confirmation. All patients except one had bilateral ground-glass opacities and/or lung consolidations in at least 2 pulmonary lobes. Inferior lobes and basal segments were the most frequent site of disease. All lung lesions had an increased FDG uptake corresponding to the interstitial pneumonia, and in one case, mediastinal nodal involvement was registered. A 59-year-old man with a previous history of oral cavity cancer treated with surgery underwent an 18 F-FDG PET/CT for restaging purpose. PET/CT was positive, showing the presence of local relapse at the right side of the tongue and several laterocervical lymph nodes (A and B). Moreover, FDG-positive plural diffuse interstitial alterations with ground-glass opacities (GGOs) appearance were registered with SUV max of 13.8 (C and D). Concomitant mediastinal nodes with increased FDG uptake were present (E). A subsequent chest radiographs confirmed a diffuse interstitial pneumonia; reverse transcriptase polymerase chain reaction (RT-PCR) was positive, and the patient was hospitalized for specific therapy. A 62-year-old man affected by follicular lymphoma underwent PET/CT scan for evaluating treatment response after 6 cycles of chemotherapy, and PET/CT showed a partial metabolic response with persistence of increased FDG uptake to an inguinal node (A-D) and the appearance of several bilateral lung consolidative and FDG-avid nodular areas, especially in the superior lobes with SUV max of 9 (E-G). Being the pattern atypical for COVID-19, the patient started new chemotherapy regimen, but after the early onset of cough and dyspnea, RT-PCR test was done with positive finding for COVID-19. Chest radiographs and CT is the preferred examinations for screening, diagnosis, and monitoring of COVID-19 pneumonia. [1] [2] [3] In this setting, the role of 18 F-FDG PET/CT is still unclear with only few cases present. 4-10 18 F-FDG PET/CT is a noninvasive tool with a significant role in evaluating several phlogistic and infectious pulmonary diseases, such as sarcoidosis and tuberculosis. 11 However, usually lesions presenting as GGOs are unlikely to have FDG uptake. 12 In agreement with previous articles, 6-8 our patients were characterized by the presence of bilateral peripheral consolidative areas and/or GGOs. All had increased FDG uptake higher than blood pool activity. COVID-19 do not seem to be associated with lymph node involvement; however, Qin et al 6 reported an increased nodal FDG uptake in 3 of 4 cases. Of course 18 F-FDG PET/CT is not routinely recommended for pulmonary lung inflammatory diseases and not indicated in an emergency setting, but our findings underline that COVID-19 pneumonia are characterized by high 18 F-FDG uptake in most cases despite GGOs appearance. Clinical Nuclear Medicine • Volume 00, Number 00, Month 2020 18 CT imaging features of 2019 novel coronavirus (2019-nCoV) Radiographic severity index in COVID-19 pneumonia: relationship to age and sex in 783 Italian patients Essentials for radiologists on COVID-19: an update radiology scientific expert panel The potential added value of FDG PET/CT for COVID-19 pneumonia FDG PET/CT of COVID-19 18 F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases 18 F-Fluorodeoxyglucose uptake in patient with asymptomatic severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019) referred to positron emission tomography/computed tomography for NSCLC restaging Incidental findings suggestive of COVID-19 in asymptomatic patients undergoing nuclear medicine procedures in a high prevalence region Incidental CT findings suspicious for COVID-19 associated pneumonia on nuclear medicine exams: recognition and management plan Nuclear medicine in SARS-CoV-2 pandemia: 18 F-FDG-PET/CT to visualize COVID-19 PET/CT in non oncological lung diseases: current applications and future perspectives Can PET/CT help manage ground glass nodules?